ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OSUR OraSure Technologies Inc

4.30
0.00 (0.00%)
Pre Market
Last Updated: 09:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
OraSure Technologies Inc NASDAQ:OSUR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.30 4.18 4.55 0 09:00:00

OraSure Technologies to Present at the 38th Annual J.P. Morgan Healthcare Conference

08/01/2020 11:00am

GlobeNewswire Inc.


OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more OraSure Technologies Charts.

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 38TH Annual J.P. Morgan Healthcare Conference.  The conference will be simultaneously webcast over the Internet.

Dr. Tang is scheduled to speak on January 15, 2020, at approximately 4:00 PM Pacific Time (7:00 PM Eastern Time).  Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com and clicking on the Investor Info link.  A replay of the webcast will be available on OraSure Technologies’ web site for seven days.  Alternatively, you can access the live webcast of the presentation via the following link: https://jpmorgan.metameetings.net/events/hc20/sessions/29646-orasure-technologies-inc/webcast

About OraSure Technologies

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries (DNA Genotek, CoreBiome, Diversigen and Novosanis), OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com. 

Company contact:

Roberto CucaJeanne Mell
Chief Financial OfficerVP Corporate Communications
610-882-1820484-353-1575
Investorinfo@orasure.commedia@orasure.com
www.orasure.comwww.orasure.com

 

1 Year OraSure Technologies Chart

1 Year OraSure Technologies Chart

1 Month OraSure Technologies Chart

1 Month OraSure Technologies Chart